Hypothesis / aims of study
Chronic pelvic pain and dyspareunia in women can be effectively managed through an interdisciplinary approach combining cognitive-behavioral therapy (CBT) with antidepressants, leading to a significant decrease in symptom duration and an overall improvement in the quality of life for patients. This method significantly reduces symptom duration and improves overall quality of life.
The study aims to evaluate the efficacy of a multimodal treatment strategy for CPP and dyspareunia in women. It also seeks to explore the impact of psychological factors, such as depression, anxiety, and trauma history, on these conditions. The goal is to assess the degree of improvement achievable through the integration of pharmacological therapy and psychotherapy.
Study design, materials and methods
This investigation utilizes a single-patient case study to provide detailed insights into clinical outcomes.
*Participant Profile*: A 26-year-old female presenting with CPP for four years. Pain intensity is rated at 8/10 on the Visual Analog Scale (VAS), while dyspareunia is rated at 7/10.
*Clinical Examination*: Comprehensive gynecological evaluation and assessment of pelvic floor muscle function.
*Psychological Assessmen*t: Anxiety and depression levels measured using the Hospital Anxiety and Depression Scale (HADS).
*Treatment Protocol:* Pharmacological intervention with SSRIs complemented by CBT and physical therapy.
*Follow-Up:* Symptom monitoring at weeks 7 and 10 post-treatment initiation.
Interpretation of results
The findings underscore the importance of addressing psychological comorbidities in managing CPP and dyspareunia. Incorporating CBT alongside SSRIs demonstrates significant benefits, not only in alleviating physical symptoms but also in enhancing patients' overall quality of life. This approach aligns with International Continence Society (ICS) standards advocating multidisciplinary care for chronic pain syndromes.